A Resolution designating the month of May 2026 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This resolution designates May 2026 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania. The resolution aims to raise public awareness about ALS, a fatal neurodegenerative disease, and acknowledge its impact on patients and families. It recognizes ongoing research efforts to find a cure for this condition.
Key provisions
- Designates May 2026 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania.
- Highlights the symptoms of ALS, including muscle weakness, difficulty swallowing, speaking, and breathing.
- Notes that ALS eventually leads to functional quadriplegia.
- States that ALS does not affect mental capacity.
- Provides statistics regarding the prevalence of ALS, including diagnosis rates, average survival time, and gender differences.
- Acknowledges the lack of known cause, prevention, or cure for ALS.
- Recognizes the importance of public awareness campaigns.
- Supports ongoing research into ALS.
Who is affected
- Individuals with Amyotrophic Lateral Sclerosis (ALS)
- Families and caregivers of individuals with ALS
- Pennsylvania residents
- Researchers studying ALS
Notable changes
- This resolution does not represent a change to existing laws or regulations.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Pn 1575 Html
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
9 on record
Primary sponsor
Cosponsors
Christine Tartaglione
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours